nach oben

Erschienen in:

01.10.2015 | Letter to the Editor

Authors’ Reply to Cotton and Nicol’s Comment on “Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study from Ethiopia”

verfasst von: Woldesellassie M. Bezabhe, Luke R. Bereznicki, Leanne Chalmers, Peter Gee, Desalew M. Kassie, Mekides A. Bimirew, Gregory M. Peterson

Erschienen in: Drug Safety | Ausgabe 10/2015

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Mark C, Simone N. Comment on: Adverse drug reactions and clinical outcomes in patients initiated on antiretroviral therapy: a prospective cohort study from Ethiopia (letter). Drug Saf. 2015. doi:10.1007/s40264-015-0334-4.

Joint United Nations Programme on HIV and AIDS (UNAIDS). Access to antiretroviral therapy in Africa. Geneva: UNAIDS; 2013. http://www.unaids.org/sites/default/files/media_asset/20131219_AccessARTAfricaStatusReportProgresstowards2015Targets_en_0.pdf. Accessed 20 July 2015.

Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM, Bimirew MA, Kassie DM. Barriers and facilitators of adherence to antiretroviral drug therapy and retention in care among adult HIV-positive patients: a qualitative study from Ethiopia. PLoS ONE. 2014;9(5):e97353. doi:10.1371/journal.pone.0097353.PubMedCentralCrossRefPubMed

Bezabhe WM, Bereznicki LR, Chalmers L, Gee P, Kassie DM, Bimirew MA, et al. Adverse drug reactions and clinical outcomes in patients initiated on antiretroviral therapy: a prospective cohort study from Ethiopia. Drug Saf. 2015;38(7):629–39. doi:10.1007/s40264-015-0295-7.CrossRefPubMed

Lima VD, Bangsberg DR, Harrigan PR, Deeks SG, Yip B, Hogg RS, et al. Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level. J Acquir Immune Defic Syndr. 2010;55(4):460–5. doi:10.1097/QAI.0b013e3181f2ac87.PubMedCentralCrossRefPubMed

Titel: Authors’ Reply to Cotton and Nicol’s Comment on “Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study from Ethiopia”
verfasst von: Woldesellassie M. Bezabhe
Luke R. Bereznicki
Leanne Chalmers
Peter Gee
Desalew M. Kassie
Mekides A. Bimirew
Gregory M. Peterson
Publikationsdatum: 01.10.2015
Verlag: Springer International Publishing
Erschienen in: Drug Safety / Ausgabe 10/2015
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI: https://doi.org/10.1007/s40264-015-0335-3

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Authors’ Reply to Cotton and Nicol’s Comment on “Adverse Drug Reactions and Clinical Outcomes in Patients Initiated on Antiretroviral Therapy: A Prospective Cohort Study from Ethiopia”

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2015

Benzodiazepine Use and Risk of Developing Alzheimer’s Disease or Vascular Dementia: A Case–Control Analysis

A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions

Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update

Evaluating Social Media Networks in Medicines Safety Surveillance: Two Case Studies

Product-Specific Regulatory Pathways to Approve Generic Drugs: The Need for Follow-up Studies to Ensure Safety and Effectiveness

Future Proofing Adverse Event Monitoring